Abstract
As in other autoimmune diseases, the inflammatory process of multiple sclerosis (MS) implicates T cells, B cells, and macrophages, and the activation of local organ-specific phagocytic cells. Particular to MS is the infiltration of the lymphocytes into the central nervous system (CNS) by crossing the blood-brain barrier (BBB) and the activation of the intrinsic immunoeffector microglia cells and of astrocytes. Although the pathologic lesions involving the brain and the spinal cord in MS can be visualized in vivo using both routine and more specific magnetic resonance imaging (MRI) techniques [1], the cellular events of CNS inflammation are difficult to observe in vivo.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Filippi M, Grossman RI (2002) MRI techniques to monitor MS evolution. The present and the future. Neurology 58: 1147–1153
Schoepf U, Marecos EM, Melder RJ et al (1998) Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 24: 642–651
Weissleder R, Cheng HC, Bogdanova A, Bogdanova A Jr (1997) Magnetically labeled cells can be detected be MR imaging. J Magn Reson Imaging 7: 258–263
Weissleder R (2001) A clearer vision for in vivo imaging. Nat Biotechnol 19: 316–317
Weissleder R, Elizondo G, Wittenberg J et al (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175: 489–493
Lee S, Weissleder R, Brady T, Wittenberg J (1991) Lymph nodes: microstructural anatomy at MR imaging. Radiology 178: 519–522
Weissleder R, Heautot JF, Schaffer BK et al (1994) MR lymphography: study of a high-efficiency lymphotropic agent. Radiology 191: 225–230
Harisinghani MG, Saini S, Weissleder R et al (1999) MR lymphography using ultra-small superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentol 172: 1347–1351
Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7: 115–121
Dousset V, Delalande C, Ballarino L et al (1999) In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 41: 329–333
Dousset V, Ballarino L, Delalande C et al (1999) Comparison of ultrasmall particles of iron oxide (USPIO) T2-weighted, conventional T2-weighted and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol 20: 223–227
Dousset V, Gomez C, Petry KG et al (1999) Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA 8: 185–189
Dousset V, Brochet B, Caillé JM, Petry KG (2000) MS lesions enhancement with ultra small particle iron oxide: the first phase II study. Rev Neurol (Paris) 156 (Suppl 3): 40
Xu S, Jordan EK, Brocke S et al (1998) Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation. J Neurosci Res 52: 549–558
Doerfler A, Engelhorn T, Heiland S et al (2000) MR contrast agents in acute experimental cerebral ischemia: potential adverse impacts on neurologic outcome and infarction size. J Magn Reson Imaging 11: 418–424
Rausch M, Baumann D, Neubacher U, Rudin M (2002) In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 15: 278–283
Rausch M, Sauter A, Frohlich J et al (2001) Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 46: 1018–1022
Enochs WS, Harsh G, Hochberg F, Weissleder R (1999) Improved delineation of human brain tumors on MR imaging using long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9: 228–232
Varallyay P, Nesbit G, Muldoon LL et al (2002) Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 23: 510–519.
Fleige G, Nolte C, Synowitz M et al (2001) Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3: 489–499
Gage F, Christen Y (eds) (1997) Isolation, characterization and utilization of CNS stem cells. Springer, Berlin Heidelberg New York
Bjornons CRR, Rietze RL, Reynolds BA et al (1999) Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283: 534–537
Eglitis M, Mezey E (1997) Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA 94: 4080–4085
Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al (2000) Adult bone marrow stromal cells differentiate into neurons in vitro. Exp Neurol 164: 247–256
Woodburry D, Schwartz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Rev 61: 364–370
Kopen GC, Prockop DJ, Phinney DG (1999) Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96: 10711–10716
Mezey E, Chandross KJ, Harta G et al (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290: 1779–1782
Bulte Jan, Zhang S, van Gelderen P et al (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: MR tracking of cell migration and myelination. Proc Natl Acad Sci USA 96: 15256–15261
Bulte JWM, Duncan ID, Frank JA (2002) In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 22: 899–907
Doche de Laquitane B, Dousset V, Solanilla A et al (2002) Iron particle labelling of haemopoietic progenitor cells: an in vitro study. Biosci Rep.
Sipe JC, Filippi M, Martino G et al (1999) Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging 17: 1521–1523
Lewin M, Carlesso N, Tung CH et al (2000) Tat peptide-derivatized magnetic nanopartides allows in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18: 410–414
Schoepf U, Marecos EM, Melder RI et al (1998) Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 24: 642–651
Weissleder R (1999) Molecular imaging: exploring the next frontier. Radiology 212: 609–614
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Italia, Milano
About this chapter
Cite this chapter
Dousset, V., Brochet, B., Caille, JM., Petry, K.G. (2003). Cell-Specific Imaging in Pathologic Conditions of the Central Nervous System, with Special Reference to Multiple Sclerosis. In: Filippi, M., Comi, G. (eds) New Frontiers of MR-based Techniques in Multiple Sclerosis. Topics in Neuroscience. Springer, Milano. https://doi.org/10.1007/978-88-470-2237-9_2
Download citation
DOI: https://doi.org/10.1007/978-88-470-2237-9_2
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2239-3
Online ISBN: 978-88-470-2237-9
eBook Packages: Springer Book Archive